Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Esophageal neoplasm metastatic

Known as: metastatic esophageal cancer, esophageal cancer, metastatic, Stage IV Esophageal Cancer 
Stage IV includes: For squamous cell carcinoma: Any T, Any N, M1, Any G, Tumor location: Any. For adenocarcinoma: Any T, Any N, M1, Any G. M1… Expand
National Institutes of Health

Related topics

Related topics

11 relations
Epithelial CellsEpitheliumEpithelium of esophagusEsophagus
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus: The Phase 2 KEYNOTE-180 Study
Importance Effective treatment options are limited for patients with advanced, metastatic esophageal cancer progressing after 2… Expand
  • table 2
  • table 1
  • figure 1
  • table 1
  • table 2
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patients
BackgroundCholesteryl pullulan (CHP) is a novel antigen delivery system for cancer vaccines. This study evaluated the safety… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Influence of sex on the survival of patients with esophageal cancer.
PURPOSE The prognostic value of sex for esophageal cancer survival is currently unclear, and growing data suggest that hormonal… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Cetuximab as Second-Line Therapy in Patients with Metastatic Esophageal Adenocarcinoma: A Phase II Southwest Oncology Group Study (S0415)
Introduction: Esophageal adenocarcinomas commonly express the epidermal growth factor receptor. This trial assessed the 6-month… Expand
Is this relevant?
2010
2010
Complementary use of fluorescence and magnetic resonance imaging of metastatic esophageal cancer in a novel orthotopic mouse model.
We describe the development of an aggressive orthotopic metastatic model of esophageal cancer, which is visualized in real time… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Review
2006
Review
2006
Chemotherapy for metastatic carcinoma of the esophagus and gastro-esophageal junction.
BACKGROUND More than 50% of patients with esophageal cancer have metastatic disease at presentation. The use of chemotherapy for… Expand
Is this relevant?
2006
2006
Mobility and invasiveness of metastatic esophageal cancer are potentiated by shear stress in a ROCK- and Ras-dependent manner.
To metastasize, tumor cells must adopt different morphological responses to resist shear forces encountered in circulating blood… Expand
Is this relevant?
2005
2005
Phase 1 Study of Weekly Polyethylene Glycol-Camptothecin in Patients with Advanced Solid Tumors and Lymphomas
Purpose: To determine the maximal tolerated dose and dose-limiting toxicities (DLT) of pegamotecan (polyethylene glycol… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer.
BACKGROUND To evaluate the activity and toxicity of docetaxel in patients with metastatic esophageal cancer. PATIENTS AND… Expand
  • table 2
  • table 1
  • figure 1
  • table 3
Is this relevant?
Highly Cited
2000
Highly Cited
2000
A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus.
PURPOSE In a phase II trial of paclitaxel, cisplatin, and fluorouracil in metastatic esophageal cancer, we identified significant… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE